Approaches to rational drug development in Alzheimer's disease.
Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, Essex, England.
L L
LL
Iversen
S D
SD
Iversen
S B
SB
Freedman
G
G
Dawson
N
N
Rupniak
R J
RJ
Hargreaves
G A
GA
Showell
L J
LJ
Street
R
R
Baker
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000473:pathology*; D016229:Amyloid beta-Peptides / Q000502:physiology; D000818:Animals; D002799:Cholinergic Fibers / Q000187:drug effects / Q000502:physiology; D015195:Drug Design; D004358:Drug Therapy / Q000639:trends*; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use
D016229:Amyloid beta-Peptides; D010277:Parasympathomimetics